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Summary: A new enzymatic method for the determination of cholesterol in serum and plasma was evaluated
in 8 separate laboratories in comparison with routine and reference methods.
Investigation of the analytical reliability in the 2-26 mmol/1 measurement ränge showed the following
results:
1. At the set reading points (10min at 25 °C and 5min at 37 °C) the reaction shows complete Substrate
conversion. The colour complex is stable over a period of 60 min.
2. The response to cholesterol is linear up to 26 mmol/1.
3. Precision within the series was 0.6—2.8% in 20 determinations (coefficient of Variation).
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4. Day to day precision was 0.5-3.3% in triple determinations of 10 days (coefficient of Variation).
5. Accuracy was studied with 2 samples (assigned value: 3.52 and 6.70 mmol/1 respectively). In the case of
sample l the mean for the 8 laboratories was 3.44, with a median of 3.44; for sample 2 the values were
6.68 and 6.72.
The results demonstrate an excellent transferability. ·'
6. In comparison with other enzymatic procedures, the values found with the new test were 5-10% higher;
these results agree at all concentration ranges with the reference methods of Abell & Kendall and with
those from mass spectrometry.
Multiientrische Erprobung einer neuen enzymatischen Cholesterinbestimmung
Zusammenfassung: Eine neue enzymatische Methode zur Bestimmung des Cholesterins in Serum und Plasma
wurde in 8 Laboratorien im Vergleich zu Routine- und Referenzmethoden evaluiert.
Die Überprüfung der analytischen Zuverlässigkeit ergab im Meßbereich zwischen 2 und 26 mmol/1 folgende
Ergebnisse:
1. Der Reaktionsverlauf zeigt zu den angegebenen Ablesezeitpunkten (25 °C: 10min und 37 °C: 5 min)
vollständigen Substratumsatz und innerhalb von 60 min gute Stabilität des Farbkomplexes.
2. Bis zu 26 mmol/1 wird das Cholesterin linear erfaßt.
3. Präzision in der Serie von 0,6-2,8% bei 20 Bestimmungen (Variationskoeffizient).
4. Präzision von Tag zu Tag von 0,5-3,3% bei 3fach-Bestimmungen an 10 Tagen (Variationskoeffizient).
5. Prüfung auf Richtigkeit mit 2 Proben (Zielwert: 3,52 bzw. 6,70 mmol/1). Bei Probe l betrug der Mittel-
wert der 8 Laboratorien 3,44 und der Median 3,44, bei Probe 2 6,68 und 6,72.
Diese Ergebnisse zeigen die sehr gute "Transfefabilität" des Testes in den verschiedenen Laboratorien.
6. Im Vergleich mit anderen enzymatischen Verfahren wurden mit dem neuen Test 5-^10% höhere Werte,
mit den Referenzmethoden nach Abell & Kendall sowie der Massenspektrometrie übereinstimmende Er-
gebnisse in allen Konzentrationsbereichen gefunden.
Introduction
The determination of cholesterol for the diagnosis
and therapy of metabolic disorders and diseases has
long been an important feature of the clinical-chemi-
cal laboratory. As a result, a large number of analyti-
cal methods based on the colour complex formation
of cholesterol äs an indicator reaction have been de-
scribed in the literature (1). The processes employ
highly caustic chemicals and are characterised, in ad-
dition to the non-specificity of the reaction, by a high
susceptibility to failure and a wide ränge of errors;
hence many study groups have been working to re-
place this chemical procedure with simple, quick and
exact methods of analysis.
The first enzymatic processes were developed in
1972 (2—4): these used cholesterol oxidase to con-
vert cholesterol into cholestenone and H2O2, follow-
ing alkaline saponification or enzymatic Splitting of
the cholesterol ester.
Cholesterol ester + H2O
Cholesterol + O2 oxidase
> Cholesterol
+ Fatty acids
> A4-Cholestenone * H2O2.
In the reaction known äs the 'catalase method' form-
aldehyde was formed from the H2O2 with methanol
in the presence of catalase; this formaldehyde. was
converted with ammonium ions and acetylacetone
into 3,5-diacetyl-l,4-dihydrolutidine. The resultant
colour was measured in the 400 nm wavelength
ränge (5, 6).
By combining this with the process developed by
Trinder, the Konversion of H2O2 with phenol and 4-
aminoantipyrine into a quinoneimine colour com-
plex, the incubation and rection times of the enzy-
matic cholesterol determination could be markedly
shortened and the practicability of the test was für-
ther improved (7, 8). **
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In comparison with the reference method (9, 10)
these enzymatic processes showed on average 4-6%
lower cholesterol values (11), which suggests an in-
complete Splitting of the cholesterol ester (12-14).
To improve the Splitting of the cholesterol ester
Boehringer Mannheim isolated new esterases, and
these were optimised into a new test in conjunction
with the phenol/4-aminoantipyrine indicator System.
The test available under the trademark 'Monotest®
Cholesterol High Performance' has the same charac-
teristics äs the monotest available up to the present,
but äs a result of its complete Splitting of the choles-
terol ester, shows a very good agreement with the
cholesterol values obtained with the reference meth-
ods.
The present report describes a multicentre study of
this new test.
The testing of the new enzymatic cholesterol followed the pro-
gram below:
1. Determination of precision within the series and from day to
day using the pool of serum produced by the laboratory itself
at three different levels of concentration. The determination of
precision within the series was carried out by means of 20 de-
terminations from one pool; the determination of day to day
precision was in triple determinations ovcr 10 days.
2. The accuracy study was conducted in triple determinations on
5 days with 2 control samples of serum. The target values for
the samples were 3.52 for Pj and 6.70 mmol/1 for ?2.
3. The linearity of measurement ränge study was carried out us-
ing a human serum with a high cholesterol concentration; this
was mixed with a 9 g/l sodium Chloride solution in an 11-step
dilution sequence and analysed in double determinations.
4. For comparison of methods, the determination procedures
customarily used in the individual laboratories were used;
these were predominantly mechanised methods.
Materials and Methods
The sample material was obtained from the laboratories of each of
the participants. The control serum used for verification was pro-
vided by Boehringer Mannheim.
The final concentration of Substrates, enzymes and detergents are
shown in Table 1.








Sodium cholate 10 mmol/1
Fatty alcohol polyethylene glycol ether 3 g/l
Cholesterol esterase 0.4 kU/1
Cholesterol oxidase 0.25 kU/1
Peroxidase 0.20 kU/1
The procedural instructions sent to all participants contained data




Serum, heparin- or EDTA^plasma
0.02ml
2ml








The reference methods followed by the external laboratories were
carried out in accordance with the published procedures (16, 17).
Results and Discussion
Reaction kinet ics
The participants in the trial monitored the course of
the reaction of the test material with sera of different
cholesterol concentrations over a period of 60 min-
utes. As the records of the changes over time of the
measurement signal show (fig. 1), a stable end pro-
duct was obtained at the recommended reading time
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Fig. l. Progress of the reactions of new Monotest® Cholesterol
High Performance with human sera. Temperature 25 °C.
A dilution series consisting of several Steps was performcd
from a human serum of a predetermined cholesterol con-
centration.
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L i n e a r i t y and ränge of measuremen t
To study the linearity ränge, all participants used hu-
man sera with a high cholesterol content diluted with
9 g/l sodium Chloride and analysed using various
types of apparatus under different reaction and mea-
surement conditions. As the results summarised in
figure 2 show, the measurement ränge of the new
enzymatic test produced linear results, without dilu-
tion of the sample, up to concentrations äs high äs 26
mmol/1.
Precision
The determination of precision within the series and
from day to day was conducted in 3 concentration
ranges and was characterised by figures for coeffl·
cients of Variation. The data presented in tables 2
and 3 show coefficients of Variation of 0.6—2.2% for
measurements within the series and 0.5—3.3% for





0.9 0.8 0.7 0.6 05 0.4 0.3 02 0.1 0
Fraction of 9 g / l NaCl inspecimen
Fig. 2. Linearity, measured using different types of apparatus:
1. Eppendorf ACP 5040 4. Technicon -
2. Hitachi 706 5. Gilford3500
3. Technicon AA-II 6. Eppendörf 1101 M
Tab. 2. Precision within the series. Measurements by the participants: in each case 20 determinations with human serum with 3 different


































































* VK = coefficient of vatiation
Tab. 3. Precision from day to day. Measurements by the participants: in each case 3 determinations on 10 days with human serum with 3







































































VK = coefficient of Variation
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Collaborative test for accuracy check
Two quantities of control sera, which were deter-
mined in an internal ring trial by the new Monotest®
cholesterol High Performance, were sent to the par-
ticipants. In order to check the accuracy of the new
cholesterol test; they were asked to determine the
cholesterol content of each sample. In sample PI the
mean value for cholesterol was 3.44, and the median
was 3.44; the assigned ('correct') value was 3.52
mmol/1. In sample P2 the assigned value was 6.70;
values of 6.68 mmol/1 were obtained for the mean
and 6.72 for the median. The deviations between the
assigned values and sample values were 0.08 mmol/1
for sample PI and 0.02 for sample ?2, corresponding
to a relative Variation of 2.3% and 0.3% respective-
Compar ison of methods
For purposes of comparison, the participants in-
cluded enzymatic methods and established chemical
and physico-chemical methods (which served äs ref-
erence methods).
A comparison of the new monotest with other enzy-
matic methods clearly showed higher cholesterol
values at all concentration ranges; the means of the
relative differences He in the ränge — l to -l· 10% (see
tab. 4).
Comparison with gas chromatography/mass spec-
trometry performed by /. Björkhem et al. (16) and
the reference methods of Abell et al. performed by
G. Boerma et al. (9) showed good agreement with
measured values (see tab. 5). In comparison with the
new enzymatic test, the reference methods gave
values that were 1% higher. This may be regarded äs
good agreement with the enzymatic method.
In the context of an extended field trial, further en-
zymatic methods and the reference method of Abell
et al. (9) were compared with the new test. These
field studies once again confirmed the results of the
test for enzymatip methods and gave a Variation of
-1% to 4-1% (17) for the reference method of
Abell et al.
Tab. 4. Comparison of Monotest® Cholesterol High Performance with other enzymatic methods1).

























































































!) Mean geometric analysis of regression (18).
2) Method I = Monotest® Cholesterol High Performance.
3) CHOD/PAP = Cholesterol oxidase/4-aminophenazone-method.
4) BM = Boehringer Mannheim.
Tab. 5. Comparison of Monotest® Cholesterol High Performance with chemical and physico-chemical methods of determination1).
Method I2) / Apparatus Method II / Apparatus Paired Slope b
values n






Extraction procedure according to Abell et al.
















') Mean geometric analysis of regression (18).
2) Method I = Monotest® Cholesterol High Performance.
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As this comparison of methods with commercially
available enzymatic procedures and with reference
methods has shown, higher cholesterol values are
found with the new enzymatic test, which is conduct-
ed using an esterase isolated from a strain of Pseu-
domonas. This is correlated with improved hydroly-
sis of the ester, s confirmed in recent studies (15).
Conlcusion
Investigations under external test conditions have
led to the recommendation that this new enzymatic
test, which has excellent transferability, be proposed
s a candidate for a reference method, since the
method is quick and simple to use and can be adopt-
ed immediately by any laboratory.
The trial participants have combined this recommen-
dation with the requirement that the Monotest®
Cholesterol High Performance be checked against
the Trimary Reference Method' at intervals and on
a batch unit basis, so that this test can then be put
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Cholesterol (Monotest* Cholesterol High Performance)(mmol/l]
Fig. 3. Comparison of methods: Monotest® Cholesterol High
Performance (x) and the Monotest in current use (y).
N = 70; slope b = 0.04; axis intercept a = -0.037 mmol/l
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3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00
Cholesterol (MonotestR Cholesterol High Performonce)[mmol/U
Fig. 4. Comparison of methods: Monotest ® Cholesterol High
Performance (x) and the reference method of Abell et al.
(y).
N = 59; slope b = 1.064; axis intercept a = 0.235 mmol/l









ΟΛΟ 2.00 400 6.00 8.00 10.00
Cholesterol (Monotest8 Cholesterol High Performonceil-mmol/ll
Fig. 5. Comparison of methods: Monotest® Cholesterol High
Performance (x) and the gas ehromatography/mass spec^
trometry reference method (y).
N = 10; slope b = 0.975; axis intercept a = 0.153 Corre-
lation coefficient r = 0.998.
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